Australia | May 02 2006
By Greg Peel
It has become relentlessly monotonous.
It wasn’t that long ago there was serious debate about super-cycles and the potential for mean reversion in commodity prices. Nowadays one doesn’t hear much debate, just a constant stream of commodity price increases, both short and long term, as analysts acknowledge the rule book is in ashes, and that not accepting spot and forward market prices will lead to some poor recommendations.
Yesterday UBS was the latest to announce material commodity price forecast increases, across the board and across the curve. This provided the first three-figure target price for Rio Tinto (RIO), $100.
Today UBS has turned to the pure-play stocks, and has pretty well run amok. Zinc is UBS’ preferred metal, and nowhere is this more obvious than in its Zinifex (ZFX) price upgrade. UBS already had Zinifex as a Buy (just as well), but across the board price increases have resulted in four stocks being lifted from Neutral to Buy today.
They are Alumina (AWC), Oxiana (OXR), Lihir Gold (LHG) and Perseverance (PSV).
UBS’ zinc price forecast has increased by 63%, 95% and 96% over 2006-08. This leads to earnings forecast increases (are you sitting down?) of 36% in FY06 and 167% in FY07. The flow through to valuation results in a 45% increase in target price from $10.00 to $14.50.
UBS is now top of the pops in Zinifex in the FN Arena database. The upgrade has pushed the average of 10 brokers’ target prices (where they provide them) to $11.80, which is 12.4% above yesterday’s close. There are 5 Buys, 3 Holds and 2 brokers who think it’s all a bit overdone (Sell), which are JP Morgan and Merrill Lynch.
UBS also pushed Alumina’s target out from $7.70 to $8.90, Oxiana from $3.00 to $4.20, Lihir from $2.70 to $3.90, and Perseverance from $0.39 to $0.55.
UBS can wear FN Arena’s coveted bull horns for now, until the next broker makes its latest move.

